title: Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 alpha-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots.
abstract: We describe a quadruple-label fluorometric immunoassay for simultaneously measuring four analytes: thyroid-stimulating hormone (TSH), 17 alpha-hydroxyprogesterone (17 alpha-OHP), immunoreactive trypsin (IRT), and creatine kinase MM (CK-MM). The assay is based on immunoreagents labeled with four different lanthanide ions (Eu3+, Tb3+, Sm3+, and Dy3+), on dissociative fluorescence enhancement applying the principle of co-fluorescence, and on time-resolved fluorometry. The monoclonal anti-alpha-TSH and anti-IRT antibodies and the polyclonal anti-CK-MM antibody were labeled with Eu3+, Sm3+, and Dy3+, respectively; 17 alpha-OHP was labeled with Tb3+. The assay was performed in microtitration strip wells coated with a mixture of monoclonal antibodies against beta-TSH, IRT, and CK-MM and a polyclonal goat anti-rabbit IgG for capture of the rabbit anti-17 alpha-OHP antibodies. After completion of the immunoreactions, the bound fractions of the lanthanides were dissociated into the co-fluorescence enhancement solution, creating highly fluorescent chelates. The four lanthanide-specific signals were subsequently measured in a time-resolved fluorometer. The detection limits of the assay were 0.1 mIU/L for TSH, 2 nmol/L for 17 alpha-OHP, 2 micrograms/L for IRT, and 4 U/L for CK-MM.
authors.affiliation: Department of Biochemistry, University of Turku, Finland.
authors.forename: Y Y
authors.initials: YY
authors.lastname: Xu
authors.forename: K
authors.initials: K
authors.lastname: Pettersson
authors.forename: K
authors.initials: K
authors.lastname: Blomberg
authors.forename: I
authors.initials: I
authors.lastname: Hemmilä
authors.forename: H
authors.initials: H
authors.lastname: Mikola
authors.forename: T
authors.initials: T
authors.lastname: Lövgren
mesh_terms: D019326:17-alpha-Hydroxyprogesterone; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis; D000911:Antibodies, Monoclonal; D003402:Creatine Kinase / Q000097:blood*; D003550:Cystic Fibrosis / Q000175:diagnosis; D004419:Dysprosium; D005063:Europium; D015200:Fluoroimmunoassay / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood*; D007037:Hypothyroidism / Q000175:diagnosis; D007202:Indicators and Reagents; D007231:Infant, Newborn; D007527:Isoenzymes; D009136:Muscular Dystrophies / Q000175:diagnosis; D015997:Neonatal Screening / Q000379:methods; D012493:Samarium; D013725:Terbium; D013972:Thyrotropin / Q000097:blood*; D014357:Trypsin / Q000097:blood*
chemical_list: D000911:Antibodies, Monoclonal; D006908:Hydroxyprogesterones; D007202:Indicators and Reagents; D007527:Isoenzymes; D013725:Terbium; D004419:Dysprosium; D012493:Samarium; D005063:Europium; D019326:17-alpha-Hydroxyprogesterone; D013972:Thyrotropin; D003402:Creatine Kinase; D014357:Trypsin